Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.110
-0.080 (-2.51%)
Aug 17, 2026, 1:44 PM CET
Arterra Bioscience Market Cap
Arterra Bioscience has a market cap or net worth of €21.24 million as of August 17, 2026. Its market cap has increased by 22.69% in one year.
Market Cap
21.24M
Enterprise Value
20.16M
Revenue
4.70M
Ranking
n/a
PE Ratio
10.59
Stock Price
€3.11
ChartMarket Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has decreased from 22.33M to 21.24M, a decrease of -4.87%. That is a compound annual growth rate of -0.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 21.24M | 5.63% |
| Dec 30, 2025 | 20.11M | 54.08% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.75B |
| DiaSorin | 3.68B |
| Amplifon | 3.35B |
| EL.En. | 1.25B |
| GPI S.p.A. | 399.24M |
| Svas Biosana | 43.77M |
| Talea Group | 40.74M |
| Helyx Industries | 19.28M |